M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

Phase 3

Recruiting

Conditions: Pulmonary Hemorrhage
Cancer

Interventions: Other: Usual Care
Drug: tranexamic acid

First Posted Date: 2021-09-23

Last Posted Date: 2024-07-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 60

Registration Number: NCT05053867

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients with Pelvic Sarcomas

Not Applicable

Recruiting

Conditions: Pelvic Sarcoma

Interventions: Other: Functional Assessment
Procedure: X-Ray Imaging

First Posted Date: 2021-09-23

Last Posted Date: 2024-10-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 130

Registration Number: NCT05054335

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma

Phase 1

Recruiting

Conditions: Myeloma

Interventions: Drug: Belantamab mafodotin

First Posted Date: 2021-09-23

Last Posted Date: 2025-01-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 30

Registration Number: NCT05055063

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Early Phase 1

Active, not recruiting

Conditions: Epithelial Ovarian
Fallopian Tube
Primary Peritoneal Cancer

Interventions: Drug: Paclitaxel/Bev (control)
Drug: Paclitaxel/Bev + ZA (experimental)

First Posted Date: 2021-09-22

Last Posted Date: 2024-10-22

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 14

Registration Number: NCT05053750

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

Not Applicable

Recruiting

Conditions: Cholangiocarcinoma Metastatic
Liver Malignant Tumors
Pancreatic Cancer
Melanoma

Interventions: Device: high dose rate brachytherapy

First Posted Date: 2021-09-22

Last Posted Date: 2024-12-06

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 60

Registration Number: NCT05053555

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women

Not Applicable

Recruiting

Conditions: Obesity-Related Malignant Neoplasm

Interventions: Device: Activity Monitor
Other: Educational Intervention
Other: Survey Administration
Behavioral: Telephone-Based Intervention

First Posted Date: 2021-09-22

Last Posted Date: 2024-11-27

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 500

Registration Number: NCT05053113

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Increasing Access to Smoking Cessation and Smoke Free Home Services for Low-Income Pregnant Women in Northeast Texas

Not Applicable

Recruiting

Conditions: Cigarette Smoking-Related Carcinoma

Interventions: Other: Informational Intervention
Other: Media Intervention
Other: Questionnaire Administration
Behavioral: Smoking Cessation Intervention
Other: Survey Administration
Behavioral: Telephone-Based Intervention
Other: Tobacco Cessation Counseling

First Posted Date: 2021-09-21

Last Posted Date: 2024-10-15

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 54158

Registration Number: NCT05051345

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone

Not Applicable

Active, not recruiting

Conditions: Lymphoma
Leukemia

Interventions: Behavioral: Exercise Intervention
Other: Counseling
Other: Informational Intervention
Dietary Supplement: Nutritional Intervention
Other: Questionnaire Administration

First Posted Date: 2021-09-20

Last Posted Date: 2024-10-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 100

Registration Number: NCT05049785

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

Recruiting

Conditions: Lung Cancer
Cancer of Thorax

Interventions: Other: Group Specific Aim 1
Other: Group Specific Aim 3
Other: Group Specific Aim 2
Other: Group Specific Aim 5
Other: Group Specific Aim 4
Other: Group Specific Aim 6

First Posted Date: 2021-09-20

Last Posted Date: 2024-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 7200

Registration Number: NCT05049837

Locations: 🇺🇸
M D Anderson Caner Center, Houston, Texas, United States

Identifying Decision Making Needs for Older Adult Women with Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy

Not Applicable

Recruiting

Conditions: Anatomic Stage I Breast Cancer AJCC V8
Anatomic Stage IA Breast Cancer AJCC V8
Anatomic Stage IB Breast Cancer AJCC V8
Anatomic Stage II Breast Cancer AJCC V8
Anatomic Stage IIA Breast Cancer AJCC V8
Anatomic Stage IIB Breast Cancer AJCC V8
Anatomic Stage III Breast Cancer AJCC V8
Anatomic Stage IIIA Breast Cancer AJCC V8
Anatomic Stage IIIB Breast Cancer AJCC V8
Anatomic Stage IIIC Breast Cancer AJCC V8

Interventions: Other: Discussion
Other: Interview
Other: Questionnaire Administration

First Posted Date: 2021-09-20

Last Posted Date: 2024-10-04

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 100

Registration Number: NCT05049746

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Home Terms & Conditions Privacy Policy